Skip to main content
Log in

Beneficio clinico e prezzo dei farmaci

  • Forum
  • Published:
PharmacoEconomics Italian Research Articles

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Bibliografia

  1. Messori A, Santarlasci B, Tripoli S, Vaiani M. Controvalore economico del farmaco e beneficio clinico: stato dell’arte della metodologia e applicazione di un algoritmo farmacoeconomico. PharmacoEconomics-Italian Research Articles 2003; 5: 53–67

    Google Scholar 

  2. Bross P, Nagamura F, Burke L, et al. Food and Drug Administration (FDA) experience with patient reported outcomes (PRO) and global quality of life (QOL) assessments in the approval of oncology drug products. Proc Am Soc Clin Oncol 2003; 22: abstract 2123

    Google Scholar 

  3. CPMP. Note for guidance of anticancer medicinal products in man. London, 2003. EMEA. Disponibile via URL all’indirizzo: http://www.emea.eu.int/pdfs/human/ewp/020595en.pdf

  4. Szucs TD, Mantovani LG. The perspective of a pharmacoeconomic study: targeting for audiences. Pharm Res 1997; 35: 471–5

    Article  CAS  Google Scholar 

  5. Drummond MF, Stoddart GL, Torrance GW. Methods for the Economic Evaluation of Health Care Programmes. Oxford; Oxford University Press, 1987

    Google Scholar 

Bibliografia

  1. Messori A, Santarlasci B, Trippoli S, Vaiani M. Controvalore economico del farmaco e beneficio clinico: stato dell’arte della metodologia e applicazione di un algoritmo farmacoecoonomico. Pharmacoeconomics-Italian Research Articles 2003; 5: 53–67

    Google Scholar 

  2. Messori A, Santarlasci B, Trippoli S, Vaiani M. Spending on statins. eBMJ http://bmj.com/cgi/eletters/327/7420/933-b#38400, 20 Oct 2003

  3. Vacca F, Pelagotti F, Messori A. Cost effectiveness of statins in men vs women. eBMJ http://bmj.com/cgi/eletters/327/7420/933-b#39209, 30 Oct 2003

  4. Messori A, Santarlasci B, Trippoli S, Vaiani M. “Polypill” to fight cardiovascular disease: cost effectiveness of statins for primary prevention of cardiovascular events is questionable (Letter). BMJ 2003; 327: 808–9.

    Article  PubMed  Google Scholar 

  5. Messori A, Santarlasci B, Trippoli S, Torricelli F. Orphan drugs in Europe: are we spending too much? eBMJ http://bmj.com/cgi/eletters/320/7245/1294#37030, 26 Sep 2003

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fattore, G., Chiroli, S., Mantovani, L.G. et al. Beneficio clinico e prezzo dei farmaci. Pharmacoeconomics-Ital-Res-Articles 6, 51–58 (2004). https://doi.org/10.1007/BF03320623

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03320623

Navigation